
Venmax Drugs & Pharmaceuticals Ltd Falls to 52-Week Low of Rs 12.36 as Sell-Off Deepens
2026-11-16 14:35:12A sharp decline of 17.71% in intraday trading dragged Venmax Drugs & Pharmaceuticals Ltd to a fresh 52-week low of Rs 12.36 on 16 Nov 2026, marking a significant underperformance against the broader market rally.
Read More
Venmax Drugs & Pharmaceuticals Ltd: Valuation Shift Signals Price Attractiveness Change
2026-11-16 08:00:17Venmax Drugs & Pharmaceuticals Ltd has experienced a notable shift in its valuation parameters, moving from a very expensive to an expensive rating. This change, coupled with its current financial metrics and market performance, suggests a cautious stance for investors amid a challenging industry backdrop.
Read MoreVenmax Drugs Gains 8.06%: Revenue Surge and Financial Turnaround Drive Weekly Move
2026-11-15 13:00:06Key Events This Week Nov 09: Stock rallies 5.40% on strong opening day Nov 11: Stock dips 1.71% despite Sensex gains Nov 12: Quarterly results reveal significant revenue growth Nov 13: Stock rebounds 4.89% amid positive financial trend report Week OpenRs.13.90 Week CloseRs.15.02<div class...
Read More
Venmax Drugs & Pharmaceuticals Ltd Reports Positive Financial Trend Amidst Challenging Market Conditions
2026-11-13 08:00:10Venmax Drugs & Pharmaceuticals Ltd has demonstrated a notable improvement in its financial performance for the quarter ended September 2026, marking a shift from a previously flat trend to a positive trajectory. Despite lingering challenges reflected in its micro-cap status and a strong sell mojo grade, the company’s recent quarterly results reveal encouraging signs of growth and operational efficiency within the Pharmaceuticals & Biotechnology sector.
Read More
Venmax Drugs & Pharmaceuticals Ltd Falls to 52-Week Low of Rs 12.75 as Sell-Off Deepens
2026-09-17 14:35:06For the third consecutive session, Venmax Drugs & Pharmaceuticals Ltd has seen its share price decline sharply, culminating in a fresh 52-week low of Rs 12.75 on 17 Sep 2026. This marks a significant 44.28% drop over the past year, considerably underperforming the Sensex, which itself is down 10.02% over the same period.
Read More
Venmax Drugs & Pharmaceuticals Ltd Falls to 52-Week Low Amidst Prolonged Downtrend
2026-09-02 14:35:10For the third consecutive session, Venmax Drugs & Pharmaceuticals Ltd has declined, culminating in a fresh 52-week low on 2 Sep 2026, as the stock slipped 7.06%% intraday. This latest drop extends a year-long slide where the share price has halved, contrasting sharply with the broader market's more modest losses.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
13-Nov-2026 | Source : BSENews paper Publication of the Unaudited Financial Results for the Quarter ended September 30 2026.
Unaudited Financial Results For The Quarter And Half Year Ended September 30 2026.
12-Nov-2026 | Source : BSEUnaudited Financial Results for the Quarter and Half Year ended September 30 206.
Statement Of Deviation & Variation
12-Nov-2026 | Source : BSEStatement of Deviation and Variation for the Quarter ended September 30 2026.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available